4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001493152-23-037136
Chief Financial Officer bought 8,000 shares at $0.81 ($6,480)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Arrow Alexander K. Chief Financial Officer | 2023-10-12 | Purchase | +8,000 | $0.81 | $6,480 | 45,815 | D |
| Open-market purchases · 8,000 sh · avg $0.81 · $6,480 | |||||||
Loading xslF345X05/ownership.xml…